Your browser doesn't support javascript.
loading
Timing of implant-removal in late acute periprosthetic joint infection: A multicenter observational study.
Wouthuyzen-Bakker, Marjan; Sebillotte, Marine; Lomas, Jose; Kendrick, Benjamin; Palomares, Eva Benavent; Murillo, Oscar; Parvizi, Javad; Shohat, Noam; Reinoso, Javier Cobo; Sánchez, Rosa Escudero; Fernandez-Sampedro, Marta; Senneville, Eric; Huotari, Kaisa; Allende, José Maria Barbero; García, Antonio Blanco; Lora-Tamayo, Jaime; Ferrari, Matteo Carlo; Vaznaisiene, Danguole; Yusuf, Erlangga; Aboltins, Craig; Trebse, Rihard; Salles, Mauro José; Benito, Natividad; Vila, Andrea; Toro, Maria Dolores Del; Kramer, Tobias Siegfried; Petersdorf, Sabine; Diaz-Brito, Vicens; Tufan, Zeliha Kocak; Sanchez, Marisa; Arvieux, Cédric; Soriano, Alex.
  • Wouthuyzen-Bakker M; Department of Medical Microbiology and Infection Prevention, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ, Groningen, the Netherlands. Electronic address: m.wouthuyzen-bakker@umcg.nl.
  • Sebillotte M; Department of Infectious Diseases and Intensive Care Medicine, Rennes University Hospital, Rennes, France.
  • Lomas J; Bone Infection Unit, Nuffield Orthopaedic Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, England.
  • Kendrick B; Bone Infection Unit, Nuffield Orthopaedic Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, England.
  • Palomares EB; Infectious Disease Service, IDIBELL-Hospital Universitari Bellvitge, Barcelona, Spain.
  • Murillo O; Infectious Disease Service, IDIBELL-Hospital Universitari Bellvitge, Barcelona, Spain.
  • Parvizi J; Rothman Institute at Thomas Jefferson University Hospital, Philadelphia, United States.
  • Shohat N; Rothman Institute at Thomas Jefferson University Hospital, Philadelphia, United States; Department of Orthopaedic Surgery, Tel Aviv University, Tel Aviv, Israel.
  • Reinoso JC; Servicio de Enfermedades Infecciosas, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.
  • Sánchez RE; Servicio de Enfermedades Infecciosas, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.
  • Fernandez-Sampedro M; Infectious Diseases Unit, Department of Medicine, Hospital Universitario Marques de Valdecilla-IDIVAL, Cantabria, Spain.
  • Senneville E; Department of Infectious Diseases, University Hospital Gustave Dron Hospital, Tourcoing, France.
  • Huotari K; Inflammation Center, Infectious Diseases, Peijas Hospital, Helsinki University Hospital and University of Helsinki, Finland.
  • Allende JMB; Department of Internal Medicine, Hospital Universitario Principe de Asturias, Madrid, Spain.
  • García AB; Department of Internal Medicine-Emergency, IIS-Fundación Jiménez Díaz, UAM, Av. Reyes Católicos 2, 28040 Madrid, Spain.
  • Lora-Tamayo J; Department of Internal Medicine, Hospital Universitario 12 de Octubre, Instituto de Investigación i+12, Madrid, Spain.
  • Ferrari MC; Department of Prosthetic Joint Replacement and Rehabilitation Center, Humanitas Research Hospital and Humanitas University, Milan, Italy.
  • Vaznaisiene D; Department of Infectious Diseases, Medical Academy, Lithuanian University of Health Sciences, Kaunas Clinical Hospital, Kaunas, Lithuania.
  • Yusuf E; Department of Microbiology, Antwerp University Hospital (UZA), University of Antwerp, Edegem, Belgium.
  • Aboltins C; The Department of Infectious Diseases, Northern Health, Melbourne, Australia; Northern Clinical School, The University of Melbourne, Melbourne, Australia.
  • Trebse R; Service for Bone Infections, Valdoltra Orthopaedic Hospital, Ankaran, Slovenia.
  • Salles MJ; Santa Casa de São Paulo School of Medical Sciences, São Paulo, Brasil.
  • Benito N; Infectious Diseases Unit, Department of Internal Medicine, Hospital de la Santa Creu i Sant Pau, Institut d'Investigació Biomèdica Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Vila A; Servicio de Infectología, Hospital Italiano de Mendoza, Mendoza, Argentina.
  • Toro MDD; Unidad Clínica de Enfermedades Infecciosa y Microbiología, Universidad de Sevilla, Instituto de Biomedicina de Sevilla (IBIS), Sevilla, Spain.
  • Kramer TS; Nationales Referenzzentrum für Surveillance von nosokomialen Infektionen am Institut für Hygiene und Umweltmedizin Charité-Universitätsmedizin, Berlin, Germany; LADR, GmbH MVZ, Neuruppin, Germany.
  • Petersdorf S; Institute of Medical Microbiology, Hospital Hygiene University Hospital, Heinrich-Heine-University. Düsseldorf, Germany.
  • Diaz-Brito V; Infectious Diseases Unit, Parc Sanitari Sant Joan de Deu, IDIBAPS, Sant Boi, Barcelona, Spain.
  • Tufan ZK; Infectious Diseases and Clinical Microbiology Department, Ankara Yildirim Beyazit University, Ataturk Training & Research Hospital, Ankara, Turkey.
  • Sanchez M; Infectious Diseases Section, Internal Medicine Service, Hospital Italiano de Buenos Aires, Argentina.
  • Arvieux C; Department of Infectious Diseases and Intensive Care Medicine, Rennes University Hospital, Rennes, France; Great West Reference centers for Complex Bone and Joint Infections (CRIOGO), France.
  • Soriano A; Service of Infectious Diseases, Hospital Clínic, University of Barcelona, Barcelona, Spain.
J Infect ; 79(3): 199-205, 2019 09.
Article en En | MEDLINE | ID: mdl-31319141
OBJECTIVES: We evaluated the treatment outcome in late acute (LA) periprosthetic joint infections (PJI) treated with debridement and implant retention (DAIR) versus implant removal. METHODS: In a large multicenter study, LA PJIs of the hip and knee were retrospectively evaluated. Failure was defined as: PJI related death, prosthesis removal or the need for suppressive antibiotic therapy. LA PJI was defined as acute symptoms <3 weeks in patients more than 3 months after the index surgery and with a history of normal joint function. RESULTS: 445 patients were included, comprising 340 cases treated with DAIR and 105 cases treated with implant removal (19% one-stage revision (n = 20), 74.3% two-stage revision (n = 78) and 6.7% definitive implant removal (n = 7). Overall failure in patients treated with DAIR was 45.0% (153/340) compared to 24.8% (26/105) for implant removal (p < 0.001). Difference in failure rate remained after 1:1 propensity-score matching. A preoperative CRIME80-score ≥3 (OR 2.9), PJI caused by S. aureus (OR 1.8) and implant retention (OR 3.1) were independent predictors for failure in the multivariate analysis. CONCLUSION: DAIR is a viable surgical treatment for most patients with LA PJI, but implant removal should be considered in a subset of patients, especially in those with a CRIME80-score ≥3.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Prótesis e Implantes / Artritis Infecciosa / Infecciones Relacionadas con Prótesis / Remoción de Dispositivos Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male Idioma: En Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Prótesis e Implantes / Artritis Infecciosa / Infecciones Relacionadas con Prótesis / Remoción de Dispositivos Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male Idioma: En Año: 2019 Tipo del documento: Article